87 related articles for article (PubMed ID: 12566788)
1. Variations in flow, duration, and concentration do not change the final lung concentration of melphalan after isolated lung perfusion in rats.
Romijn S; Hendriks JM; Van Putte BP; Guetens G; De Bruijn EA; Van Schil PE
Eur Surg Res; 2003; 35(1):50-3. PubMed ID: 12566788
[TBL] [Abstract][Full Text] [Related]
2. Selective pulmonary artery perfusion with melphalan is equal to isolated lung perfusion but superior to intravenous melphalan for the treatment of sarcoma lung metastases in a rodent model.
Den Hengst WA; Hendriks JM; Van Hoof T; Heytens K; Guetens G; de Boeck G; Lardon F; Van Schil PE
Eur J Cardiothorac Surg; 2012 Aug; 42(2):341-7; discussion 347. PubMed ID: 22345285
[TBL] [Abstract][Full Text] [Related]
3. Regional differences of melphalan lung levels after isolated lung perfusion in the rat.
Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G; Van Schil PE
J Surg Res; 2005 May; 125(2):157-60. PubMed ID: 15854668
[TBL] [Abstract][Full Text] [Related]
4. Anterograde versus retrograde isolated lung perfusion with melphalan in the WAG-Rij rat.
Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G G; De Bruijn EA; Van Schil PE
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1083-5. PubMed ID: 15896622
[TBL] [Abstract][Full Text] [Related]
5. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model.
Van Putte BP; Hendriks JM; Romijn S; Guetens G; De Boeck G; De Bruijn EA; Van Schil PE
Ann Thorac Surg; 2002 Sep; 74(3):893-8; discussion 898. PubMed ID: 12238857
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trial.
Grootenboers MJ; Hendriks JM; van Boven WJ; Knibbe CA; van Putte B; Stockman B; De Bruijn E; Vermorken JB; Van Schil PE; Schramel FM
J Surg Oncol; 2007 Dec; 96(7):583-9. PubMed ID: 17999399
[TBL] [Abstract][Full Text] [Related]
7. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma.
Nawata S; Abecasis N; Ross HM; Abolhoda A; Cheng H; Sachar KS; Burt ME
J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1542-7; discussion 1547-8. PubMed ID: 8975846
[TBL] [Abstract][Full Text] [Related]
8. Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma.
Hendriks JM; Van Schil PE; De Boeck G; Lauwers PR; Van Oosterom AA; Van Marck EA; Eyskens EJ
Ann Thorac Surg; 1998 Nov; 66(5):1719-25. PubMed ID: 9875778
[TBL] [Abstract][Full Text] [Related]
9. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
Rothbarth J; Sparidans RW; Beijnen JH; Schultze-Kool LJ; Putter H; van de Velde CJ; Mulder GJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):736-40. PubMed ID: 12388659
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases.
Van Putte BP; Hendriks JM; Romijn S; Pauwels B; Vermorken JB; Van Schil PE
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):125-30. PubMed ID: 15999051
[TBL] [Abstract][Full Text] [Related]
11. Melphalan dosing regimens for management of recurrent melanoma by isolated limb perfusion: application of a physiological pharmacokinetic model based on melphalan distribution in the isolated perfused rat hindlimb.
Wu ZY; Smithers BM; Roberts MS
Melanoma Res; 1997 Jun; 7(3):252-64. PubMed ID: 9195565
[TBL] [Abstract][Full Text] [Related]
12. Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation.
van Iersel LB; Verlaan MR; Vahrmeijer AL; van Persijn van Meerten EL; Tijl FG; Sparidans RW; Gelderblom H; Kuppen PJ; Tollenaar RA; van de Velde CJ
Eur J Surg Oncol; 2007 Sep; 33(7):874-81. PubMed ID: 17400422
[TBL] [Abstract][Full Text] [Related]
13. Isolated lung perfusion with melphalan: pharmacokinetics and toxicity in a pig model.
van der Elst A; Oosterling SJ; Paul MA; Vonk AM; Sparidans RW; van der Sijp JR
J Surg Oncol; 2006 Apr; 93(5):410-6. PubMed ID: 16550578
[TBL] [Abstract][Full Text] [Related]
14. Isolated lung perfusion with melphalan prolongs survival in a rat model of metastatic pulmonary adenocarcinoma.
Hendriks JM; Van Schil PE; Van Oosterom AA; Kuppen PJ; Van Marck E; Eyskens E
Eur Surg Res; 1999; 31(3):267-71. PubMed ID: 10352355
[TBL] [Abstract][Full Text] [Related]
15. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial.
Hendriks JM; Grootenboers MJ; Schramel FM; van Boven WJ; Stockman B; Seldenrijk CA; ten Broecke P; Knibbe CA; Slee P; De Bruijn E; Vlaeminck R; Heeren J; Vermorken JB; van Putte B; Romijn S; Van Marck E; Van Schil PE
Ann Thorac Surg; 2004 Dec; 78(6):1919-26; discussion 1926-7. PubMed ID: 15561001
[TBL] [Abstract][Full Text] [Related]
16. Tissue and perfusate pharmacokinetics of melphalan in isolated perfused rat hindlimb.
Wu ZY; Smithers BM; Roberts MS
J Pharmacol Exp Ther; 1997 Sep; 282(3):1131-8. PubMed ID: 9316818
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of melphalan in isolated limb perfusion.
Norda A; Loos U; Sastry M; Goehl J; Hohenberger W
Cancer Chemother Pharmacol; 1999; 43(1):35-42. PubMed ID: 9923539
[TBL] [Abstract][Full Text] [Related]
18. Phase II multicenter clinical trial of pulmonary metastasectomy and isolated lung perfusion with melphalan in patients with resectable lung metastases.
den Hengst WA; Hendriks JM; Balduyck B; Rodrigus I; Vermorken JB; Lardon F; Versteegh MI; Braun J; Gelderblom H; Schramel FM; Van Boven WJ; Van Putte BP; Birim Ö; Maat AP; Van Schil PE
J Thorac Oncol; 2014 Oct; 9(10):1547-53. PubMed ID: 25105436
[TBL] [Abstract][Full Text] [Related]
19. Quality of life evolution after pulmonary metastasectomy: a prospective study comparing isolated lung perfusion with standard metastasectomy.
Balduyck B; Van Thielen J; Cogen A; Den Hengst W; Hendriks J; Lauwers P; Van Schil P
J Thorac Oncol; 2012 Oct; 7(10):1567-673. PubMed ID: 22982657
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion.
de Wilt JH; ten Hagen TL; de Boeck G; van Tiel ST; de Bruijn EA; Eggermont AM
Br J Cancer; 2000 Mar; 82(5):1000-3. PubMed ID: 10737379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
